Length of interdialytic interval influences serum calcium and phosphorus concentrations

Nephrology Dialysis Transplantation

Volumn 20, Issue 8, 2005, Pages 1643-1646

  Sigrist, Mhairi K ^a   Devlin, Lisa ^a   Taal, Maarten W ^a   Fluck, Richard J ^a   McIntyre, Christopher W ^a,b  

^a DERBY CITY GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Calcium carbonate; Haemodialysis; Interdialytic interval; Phosphate; Sevelamer; Vascular calcification

Indexed keywords

CALCICHEW; CALCIUM CARBONATE; CALCIUM ION; HEMOGLOBIN; PHOSPHATE BINDING AGENT; PHOSPHORUS; SERUM ALBUMIN; SEVELAMER;

ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; DIALYSATE; DIET; DOSE RESPONSE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; MAJOR CLINICAL STUDY; MORTALITY; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

CALCIUM; DIALYSIS SOLUTIONS; EPOXY COMPOUNDS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHOSPHORUS; POLYAMINES; POLYETHYLENES; RENAL DIALYSIS;

EID: 26444602081     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh874     Document Type: Article

References (11)

1. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740
2. Drueke TB, Rostand SG. Progression of vascular calcification in uraemic patients: Can it be stopped? Nephrol Dial Transplant 2002; 17: 1365-1368
3. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
4. Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 2004; 66: 2293-2299
5. Reynolds JL, Joannides AJ, Skepper JN et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867
6. Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1489-1496
7. Ring T, Sanden AK, Hansen HH, Halkier P, Nielsen C, Fog L. Ultradian variation in serum phosphate concentration in patients on haemodialysis. Nephrol Dial Transplant 1995; 10: 59-63
8. Chertow G, Burke S, Dillon M, Slatopolsky E. Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients. Nephrol Dialysis Transplant 1999; 14: 2907-2914
9. Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252
10. Sigrist MK, Bungay P, McIntyre CW. Vascular calcification and its attendant consequences: A comparison between CKD 4, peritoneal dialysis and haemodialysis. J Am Soc Nephrol 2004; 15: 174A
11. Lindsay RM, Alhejaili F, Nesrallah G et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 2003; 42 [1 Suppl]: 4-9